NCT06853665View on ClinicalTrials.gov

The TEAM Study - Treatment Efficacy for Autism/Attention Using Mixed Amphetamine

PHASE4Not yet recruitingINTERVENTIONAL
Enrollment

196

Participants

Timeline

Start Date

October 15, 2025

Primary Completion Date

October 15, 2029

Study Completion Date

October 15, 2029

Conditions
Attention Deficit Hyperactivity Disorder (ADHD)AutismAutism Spectrum Disorder
Interventions
DRUG

Adderall XR (mixed salts amphetamine)

Capsule

DRUG

Placebo

Capsule

Trial Locations (1)

02114

Massachusetts General Hospital, Boston

All Listed Sponsors
collaborator

Massachusetts Institute of Technology (MIT)

UNKNOWN

lead

Gagan Joshi

OTHER